More than 7,500 women are diagnosed with ovarian cancer every year. LADYMAYPIX/ Shutterstock A drug that can treat chemotherapy-resistant ovarian cancer has just been approved for use on the NHS in England. Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years. In the UK, over 7,500 women are diagnosed with ovarian cancer every year. By 2040, it’s predicted this number will rise to 9,400. For more than 30 years,